期刊文献+

犬呼吸道冠状病毒研究进展 被引量:10

Progress on Canine Respiratory Coronavirus
在线阅读 下载PDF
导出
摘要 犬呼吸道冠状病毒与大家熟悉的肠炎型犬冠状病毒不同,该病毒属于第2群冠状病毒,常见于犬传染性呼吸道疾病的早期,主要侵害上呼吸道并引起轻度呼吸道症状,在临床上易并发与其他呼吸道病原体的混合感染。该病毒最常存在于气管和咽扁桃体,推荐的诊断方法为RT-PCR,治疗主要是防止继发感染,目前尚无针对该病毒的疫苗用于预防此病。为了更加全面和深入地认识该病毒及其所引起的疾病,论文从该病病原学、流行病学、临床症状、病理变化、发病机理、诊断、治疗和预防等方面进行综述。 Canine respiratory coronavirus (CRCoV) is unlike the well-known enteric canine coronaviruses (CCoV) ,and belongs to group 2 coronaviruses. It is frequently detected at the early stage of canine infec-tious respiratory disease(CIRD) and mainly damages the upper respiratory tract,leading to mild respiratory symptoms, the co-infection with other respiratory pathogens is easily found in clinic. This virus most oftenexists in tracheas and pharyngeal tonsils, RT-PCR is the reccommnded method to make diagnosis. As to treatment, the main work is to control secondary infections. Currently,there is no vaccine against the virusto prevent the disease. In order to know CRCoV and the causing disease more completely,the etiology,epi- demiology, clinical symptoms, pathological lesions, pathogenesis, diagnosis, treatment and prevention of thedisease were reviewed in this paper.
作者 肖园 吕艳丽
出处 《动物医学进展》 北大核心 2016年第9期91-94,共4页 Progress In Veterinary Medicine
关键词 犬呼吸道冠状病毒 流行病学 临床症状 病理变化 诊断 Canine respiratory coronavirus epidemiology clinical symptom pathological lesion diagnosis
  • 相关文献

参考文献28

  • 1Mitchell J A,Brownlie J.The challenges in developing effective canine infectious respiratory disease vaccines[J].J Pharm Phar- macol,2015,67(3):372-381.
  • 2Erles K,Toomey C,Brooks H W,et al.Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease [J].Virology,2003,310(2):216-223.
  • 3邓均华,韩水仲,李红,等.犬流感研究进展//第十五次全国养犬学术研讨会暨第七次全国小动物医学学术研讨会论文集[C].江西南昌:江西农业大学,2013:24-29.
  • 4Zumla A,Hui D S,Perlman S.Middle East respiratory syn- drome[J].Lancet,2015,386(9997):995-1007.
  • 5Alsolamy S.Middle East respiratory syndrome:knowledgd to date[J].Crit Care Med,2015,43(6):1283-1290.
  • 6Hilgenfeld R.From SARS to MERS:crystallographic studies on coronaviral proteases enable antiviral drug design[J].FEBS J,2014,281(18):4085-4096.
  • 7Rasmussen S A,Gerber S I,Swerdlow D L.Middle East respir- atory syndrome coronavirus:update for clinicians[J].Clin In- fect Dis,2015,60(11):1686-1689.
  • 8Tennant B J,Gaskell R M,Jones R C,et al.Studies on the epi- zootiology of canine coronavirus[J].Vet Rec,1993,132(1):7-11.
  • 9阮红梅,张健之.中东呼吸综合征冠状病毒(M ERS-CoV)的研究进展[J].中国人兽共患病学报,2014,30(8):848-854. 被引量:23
  • 10Kaneshima T,Hohdatsu T,Hagino R,et al.The infectivity and pathogenicity of a group 2 bovine coronavirus in pups[J].J Vet Med Sci,2007,69(3):301-303.

二级参考文献146

  • 1孙东波,冯力,陈建飞,时洪艳,佟有恩,刘胜旺,陈洪岩.猪流行性腹泻病毒CH/JL毒株S基因的克隆、序列分析及线性抗原表位区的鉴定[J].病毒学报,2007,23(3):224-229. 被引量:21
  • 2Lu L, Liu Q, Du L, et al. Middle East respiratory syndrome corona- virus (MERS-CoV): challenges in identifying its source and con- trolling its spread[J]. Microbes and Infection,2013,15: 625-629.
  • 3Gorbalenya A E, Enjuanes L, Ziebuhr J, et al. Nidovirales : Evolving the largest RNA virus genome[J]. Virus Res,2006,117(1) :17 37.
  • 4Kushnir N, Streatfield S J, Yusibov V. Virus-like particles as a high ly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development[J]. Vaccine, 2012, 31 (1) 58-83.
  • 5Ouill6n G-, Aguilar J C, Duefias S, et al. Virus-Like Particles as vac- cine antigens and adjuvants: application to chronic disease, cancer immunotherapy and infectious disease preventive strategiesrJ. Pro- cedia Vaccinol,2010,2(2) : 128 133.
  • 6Grgacic E V L,Anderson D A. Virulike particles; Passport to im- mune recognition[J]. Methods,2006,40(1) 60-65.
  • 7Rychlowska M,Gromadzka B, Bienkowska-Szewczyk K, et al. Ap- plication of baculovirus-insect cell expression system for human therapyJ. Current Pharmaeeut Bioteehnol, 2011,12 : 1840-1849.
  • 8Patel J R, Heldens J O M, Bakonyi T, et al. Important mammalian veterinary viral immunodiseases and their control[J]. Vaccine, 2012, 30(10) :1767-1781.
  • 9Chen H Y,Wurm T,Britton P, et al. Interaction of the coronavirus nucleoprotein with nucleolar antigens and the host cellJ. J Virol, 200276(10) :5233 5250.
  • 10Calvo E, Escors D, Lopez J A, et al. Phosphorylation and subcellu- lar localization of transmissible gastroenteritis virus nucleocapsid protein in infected cells[J]. J Gen Virol,2005,86(8) : 2255-2267.

共引文献59

同被引文献68

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部